Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 18, 2023American Journal of HematologyOpen Access

Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first‐line therapy with hypomethylating agents alone or in combination with Venetoclax

View Full Paper
Ask AI
Bookmark
Share

Authors

ACAnna CandoniUniversity of SienaDLDavide LazzarottoAzienda Sanitaria Universitaria Integrata di TriesteCPCristina PapayannidisIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Candoni et al. (2023) studied this question.

synapsesocial.com/papers/6a7b53f6bdf697b3de02ed4chttps://doi.org/10.1002/ajh.26846
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents2019 · 87 citations
  2. 2How I treat acute myeloid leukemia in the era of new drugs2019 · 308 citations
  3. 3NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.20212021 · 336 citations
  4. 4Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia2020 · 2,955 citations
  5. 5Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel2016 · 5,999 citations